Publication | Closed Access

The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives

Breast OncologyOncologyCancer EpidemiologyPalb2 Germline MutationsSomatic VariantMedicineGeneticsPathologyBreast CancerCancer GeneticsMolecular DiagnosticsRadiation Oncology